Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lead-in observational study of FIX/FVIII prophylaxis in adult severe hemophilia A and B prior to AAV gene therapy
jRCT1080224578Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label trial of coagulation factor IX and Factor VIII in hemophilia B (HB) and hemophilia A (2 arms), sponsored by Pfizer. Started Mar 2019; status: completed.
02
Drugs
coagulation factor IXFactor VIII
03
Conditions
hemophilia B (HB)hemophilia A
Beyond the preview
Go deeper on jRCT1080224578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224578.